≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Type 1 diabetes, wide definition, subgroup 2

DOID EFO Endpoint Browser

T1D_WIDE2

type I diabetes mellitus: A chronic condition characterized by minimal or absent production of insulin by the pancreas.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • not PANCREATITIS
  • and not INSULIN_INTER_AND_LONG
  • and KELA_DIAB_INSUL
  • and INSULIN_SHORTFAST
1180

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

724

6. Filter based on genotype QC (FinnGen only)

724

Control definitions (FinnGen only)

Control exclude
DIABETES_FG
Control conditions
not PANCREATITIS
and not INSULIN_INTER_AND_LONG
and not KELA_DIAB_INSUL
and not INSULIN_SHORTFAST

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8193 3476 4409
Only index persons 2249 991 1258
Unadjusted period prevalence (%)
Whole population 0.12 0.10 0.12
Only index persons 0.04 0.04 0.05
Median age at first event (years)
Whole population 53.87 58.28 50.15
Only index persons 48.96 53.50 45.38

-FinnGen-

Key figures

All Female Male
Number of individuals 724 322 402
Unadjusted period prevalence (%) 0.15 0.11 0.18
Median age at first event (years) 55.80 56.23 55.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
694
Matched controls
6941
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
16384.0
323.0
538
*
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
+∞
323.0
301
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6837.3
323.0
623
9
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
233.2
323.0
386
37
A10AA01
ATC
NA
+∞
323.0
362
*
103
Kela drug reimbursment
Diabetes, insulin-treated
+∞
323.0
694
*
A10AA02
ATC
NA
+∞
323.0
480
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2238.0
304.7
273
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4005.3
303.1
270
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
+∞
298.0
264
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3771.4
290.7
260
*
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3124.6
254.3
230
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2964.8
244.7
222
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
235.1
212
*
A10BB01
ATC
glibenclamide; oral
1487.3
227.3
209
*
A10BA02
ATC
metformin; oral
83.1
215.3
237
43
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
+∞
196.4
179
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
+∞
180.3
165
*
H04AA01
ATC
glucagon; nasal, parenteral
+∞
151.8
140
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
+∞
121.5
113
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
+∞
115.9
108
*
A10AA03
ATC
NA
+∞
114.8
107
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
+∞
113.7
106
*
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
620.6
110.0
106
*
T89
ICPC
Diabetes insulin dependent
613.7
108.9
105
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
+∞
96.1
90
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
117.6
86.3
92
9
A10AE05
ATC
insulin detemir; parenteral
+∞
84.1
79
*
A98
ICPC
Health maint/preventive medicine
0.2
82.3
210
4718
A10AE04
ATC
insulin glargine; parenteral
409.4
75.3
74
*
A10BX01
ATC
guar gum; systemic
23.1
75.2
110
56
A10BB12
ATC
glimepiride; oral
209.7
73.7
75
*
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
+∞
71.1
67
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
+∞
68.9
65
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
65.7
62
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
+∞
65.7
62
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
+∞
63.5
60
*
H3601, E113
ICD-10 Finland
NA
+∞
62.4
59
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
+∞
62.4
59
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
60.3
57
*
H3603, E113
ICD-10 Finland
NA
+∞
60.3
57
*
C09AA02
ATC
enalapril; systemic
4.3
58.8
277
926
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
311.3
57.1
57
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.7
56.9
186
420
2507A
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI II]
+∞
53.8
51
*
C02EA02
ATC
NA
8.3
53.5
126
180
H3600, E113
ICD-10 Finland
NA
+∞
52.8
50
*
205
Kela drug reimbursment
Chronic hypertension
3.6
51.0
333
1430
XCK10
NOMESCO Finland
Photography of fundus of eye
6.6
50.2
140
255
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
268.8
49.7
50
*
H3600, E103
ICD-10 Finland
NA
+∞
49.6
47
*
H36.01
ICD-10 Finland
Diabetic maculopathy
+∞
49.6
47
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
16.0
48.4
80
56
CKC10
NOMESCO Finland
Local photocoagulation of retina
25.0
48.1
68
30
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
+∞
47.4
45
*
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
+∞
47.4
45
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
+∞
46.4
44
*
C03CA01
ATC
furosemide; systemic
3.2
46.2
387
1956
H3603, E103
ICD-10 Finland
NA
+∞
44.2
42
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
44.2
42
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
8.4
44.0
102
140
T90
ICPC
Diabetes non-insulin dependent
10.0
43.4
90
102
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.3
41.4
138
309
2505A
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI II]
+∞
41.0
39
*
2500X
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]
+∞
41.0
39
*
NGQ20
NOMESCO Finland
Amputation of lower leg
80.2
40.4
45
6
A10BB07
ATC
glipizide; oral
217.4
40.3
41
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
40.0
38
*
NHQ40
NOMESCO Finland
Amputation of toe
18.3
39.7
62
37
A12AA04
ATC
calcium carbonate; oral
19.2
39.1
60
34
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
+∞
38.9
37
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
45.6
38.6
47
11
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
+∞
37.8
36
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
387.0
37.4
37
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
11.7
37.0
70
66
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
+∞
35.7
34
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
+∞
35.7
34
*
A11CC03
ATC
alfacalcidol; systemic
11.8
33.2
62
57
J01DA01
ATC
[U] cefalexin; systemic
2.7
32.9
472
3059
N02BE01
ATC
paracetamol; systemic, rectal
0.4
32.7
276
4407
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
75.6
32.2
36
5
C09AA01
ATC
captopril; oral
9.0
31.0
67
81
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
30.4
29
*
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
+∞
30.4
29
*
C01DA14
ATC
isosorbide mononitrate; oral
2.9
30.3
241
1089
B03XA01
ATC
erythropoietin; parenteral
18.1
29.7
46
27
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
+∞
29.4
28
*
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.6
29.2
293
1513
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
+∞
28.3
27
*
M01AH05
ATC
etoricoxib; oral
0.3
27.0
79
2045
H43.1
ICD-10 Finland
Vitreous haemorrhage
10.3
26.7
53
55
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
+∞
26.2
25
*
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
+∞
26.2
25
*
81
HP
Angiography of the heart and coronary arteries
4.1
26.2
110
304
SPAT1262
SPAT
Handing over of treatment supplies
3.9
25.9
117
345
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
12.9
25.9
46
38
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
46.2
25.7
31
7
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
+∞
25.1
24
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.9
25.0
58
79
WX110
NOMESCO Finland
Local anesthesy
0.4
24.9
141
2760
A12BA01
ATC
potassium chloride; oral
4.1
24.9
104
286
I50.1
ICD-10 Finland
Left ventricular failure
4.3
24.4
96
249
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.5
24.3
239
1191
137
Kela drug reimbursment
Uraemia requiring dialysis
19.9
24.1
36
19
C01AA05
ATC
digoxin; systemic
3.0
23.6
158
623
C10AB02
ATC
bezafibrate; oral
16.0
23.5
38
25
SPAT1053
SPAT
Memory test
0.1
23.4
7
761
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
25.7
23.2
32
13
B01AC07
ATC
dipyridamole; systemic
3.7
23.2
110
337
H3601, E103
ICD-10 Finland
NA
+∞
23.0
22
*
N083, E112
ICD-10 Finland
NA
+∞
23.0
22
*
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
9.3
22.9
48
55
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
4.2
22.6
92
246
40199
ICD-8 Finland
Essential benign hypertension
7.9
22.6
52
70
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.4
22.2
249
1318
J01FF01
ATC
clindamycin; systemic
2.6
22.1
195
906
SAA01
NOMESCO Finland
Simple examination of mouth
0.4
21.5
140
2639
I25.2
ICD-10 Finland
Old myocardial infarction
3.4
21.2
113
378
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
29.1
21.1
28
10
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
20.9
20
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
20.9
20
*
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
+∞
20.9
20
*
I50.0
ICD-10 Finland
Congestive heart failure
3.1
20.6
128
478
C08DB01
ATC
diltiazem; oral
3.5
19.9
99
314
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.7
19.5
158
693
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
16.4
18.9
30
19
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
6.6
18.9
49
79
2506A
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,TYYPPI II]
+∞
18.8
18
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
18.8
18
*
A10AC30
ATC
combinations; parenteral (insulins and analog. for injection, intermediate-acting)
+∞
18.8
18
*
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
71.9
18.8
21
*
SAA02
NOMESCO Finland
Basic examination of mouth
0.4
18.8
119
2299
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.7
18.7
87
261
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.4
18.6
71
1679
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
39.6
18.6
23
6
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
16.7
18.5
29
18
V03AE01
ATC
polystyrene sulfonate; oral
11.5
18.4
34
31
B05DA
ATC
Isotonic solutions
18.2
18.4
28
16
P20
ICPC
Memory disturbance
0.1
18.3
8
658
D03BA52
ATC
collagenase, combinations; topical
15.9
18.1
29
19
E11
ICD-10 Finland
Type 2 diabetes mellitus
8.3
18.0
40
51
C02DE04
ATC
NA
4.5
17.9
66
160
TK800
NOMESCO Finland
Hemodialysis
9.7
17.8
36
39
2504A
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYP II]
+∞
17.8
17
*
XCK20
NOMESCO Finland
NA
+∞
17.8
17
*
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
+∞
17.8
17
*
N083, E102
ICD-10 Finland
NA
+∞
17.8
17
*
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
+∞
17.8
17
*
NFQ20
NOMESCO Finland
Amputation of femur
12.9
17.8
31
25
D01AC02
ATC
miconazole; topical
3.4
16.9
87
282
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
15.5
16.8
27
18
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
+∞
16.7
16
*
J01MA01
ATC
ofloxacin; systemic
3.0
16.7
102
373
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
92.3
16.6
18
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.3
16.6
191
998
A10BH01
ATC
sitagliptin; oral
173.9
16.6
17
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
6.3
16.5
44
74
S18
ICPC
Laceration/cut
0.4
16.3
76
1666
Z49.1
ICD-10 Finland
Extracorporeal dialysis
11.1
16.1
30
28
B05DB
ATC
Hypertonic solutions
19.1
16.1
24
13
SPAT1301
SPAT
No procedures
0.4
15.8
56
1382
2505B
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]
+∞
15.7
15
*
2506B
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,TYYPPI I]
+∞
15.7
15
*
B06AA55
ATC
streptokinase, combinations; systemic, topical
46.1
15.1
18
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.3
15.0
25
891
4289X
ICD-9 Finland
Heart failure, unspecified
12.8
15.0
26
21
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.3
14.9
37
1074
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
4.7
14.9
51
115
SPAT1325
SPAT
Vaccination
0.4
14.9
71
1553
SPAT1216
SPAT
Assessment of functional ability
0.2
14.9
17
745
Z01.2
ICD-10 Finland
Dental examination
0.4
14.7
59
1385
M04AA01
ATC
allopurinol; systemic
2.5
14.7
123
541
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
21.6
14.7
21
10
H28.0*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic cataract
+∞
14.6
14
*
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
5.3
14.5
44
87
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.3
14.4
24
853
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.4
14.3
54
1303
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.4
14.2
95
1836
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.2
14.2
11
616
SPAT1263
SPAT
Sampling
0.4
14.1
90
1770
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
4.5
13.9
49
114
SPAT1312
SPAT
General health counselling
0.4
13.8
48
1202
GD1AA
NOMESCO Finland
Thorax X-ray examination
0.5
13.7
107
1968
40299
ICD-8 Finland
Hypertensive heart disease
12.4
13.7
24
20
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
76.6
13.6
15
*
E10.0
ICD-10 Finland
Type 1 diabetes mellitus, With coma
+∞
13.6
13
*
25004
ICD-8 Finland
Diabetes mellitus, Nephropathia diabetica. Polyneuritis diabetica
+∞
13.6
13
*
2503A
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI II]
+∞
13.6
13
*
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
+∞
13.6
13
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
+∞
13.6
13
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.5
13.3
97
1828
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.8
13.3
89
346
SPAT1153
SPAT
Removal of sutures
0.4
13.2
48
1180
K02.1
ICD-10 Finland
Caries of dentine
0.5
13.1
107
1944
B04AC02
ATC
NA
19.5
13.0
19
10
11
HP
Coronary artery bypass surgery
4.7
12.9
44
99
K85
ICPC
Elevated blood pressure
0.2
12.9
9
538
KMAK
NOMESCO Finland
NA
0.5
12.7
92
1744
N06AA09
ATC
amitriptyline; systemic
2.9
12.7
81
305
A10BK03
ATC
empagliflozin; oral
71.2
12.6
14
*
5315
FHL
Bypass surgery using a mammary artery
6.2
12.5
33
55
SPAT1310
SPAT
Counselling related to known health issue
0.4
12.5
46
1131
25005
ICD-8 Finland
Diabetes mellitus, Neuropathia diabetica. Polyneuritis diabetica
+∞
12.5
12
*
2507X
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICATIONE ALIA ,NUD]
+∞
12.5
12
*
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
12.5
12
*
H360, E113
ICD-10 Finland
NA
+∞
12.5
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.8
12.5
274
1809
SPAT1222
SPAT
Counselling/guidance promoting independent living
0.2
12.5
19
711
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
132.2
12.5
13
*
C02EA01
ATC
NA
6.4
12.4
32
52
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
3.8
12.2
52
145
K86
ICPC
Hypertension uncomplicated
0.1
12.2
*
384
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
12.2
223
1380
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.4
12.2
50
1172
J01DB01
ATC
cefalexin; oral
0.6
12.1
297
3961
H81
ICPC
Excessive ear wax
0.2
12.1
17
667
N18.8
ICD-10 Finland
Other chronic renal failure
5.2
12.0
37
75
N18.0
ICD-10 Finland
End-stage renal disease
7.8
12.0
27
36
S82
ICPC
Naevus/mole
0.1
12.0
*
354
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
47.5
11.9
14
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.5
11.9
99
1798
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.4
11.8
42
1045
A28
ICPC
Limited function/disability NOS
0.3
11.8
28
839
Z49.0
ICD-10 Finland
Preparatory care for dialysis
16.7
11.7
18
11
C03DA01
ATC
spironolactone; oral
2.4
11.7
103
466
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
3.4
11.6
56
173
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
11.6
168
947
C09BA02
ATC
enalapril and diuretics; systemic
3.0
11.6
70
253
M79.6
ICD-10 Finland
Pain in limb
0.4
11.5
61
1301
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
0.5
11.5
99
1782
N08.3
ICD-10 Finland
Glomerular disorders in diabetes mellitus
+∞
11.5
11
*
E11.01
ICD-10 Finland
Non-insulin dependent diabetes diabetic coma with hyperglycaemia
+∞
11.5
11
*
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
+∞
11.5
11
*
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
121.9
11.5
12
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.2
11.4
15
611
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
12.1
11.4
20
17
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
4.1
11.4
44
113
H13
ICPC
Plugged feeling ear
0.3
11.4
21
711
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.2
11.3
11
538
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
0.1
11.3
*
335
B01AB05
ATC
enoxaparin; parenteral
0.4
11.3
54
1194
280
Kela drug reimbursment
Clopidogrel
5.5
11.2
32
60
M54.5
ICD-10 Finland
Low back pain
0.4
11.1
48
1105
J01DA06
ATC
[U] cefuroxime; systemic
2.3
11.1
104
485
C09AA03
ATC
lisinopril; oral
3.6
11.1
49
142
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.2
11.0
11
528
CKC12
NOMESCO Finland
Photocoagulation of retina
5.4
11.0
32
61
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
3.6
11.0
49
143
N02AX02
ATC
tramadol; systemic, rectal
1.8
10.9
265
1789
C08CA02
ATC
felodipine; oral
2.5
10.9
90
393
4120B
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]
5.5
10.8
31
58
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.5
10.8
90
396
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
4.5
10.8
37
85
Z49.2
ICD-10 Finland
Other dialysis
13.2
10.7
18
14
G04AC01
ATC
NA
3.8
10.7
44
120
C03BA08
ATC
metolazone; oral
60.9
10.6
12
*
C07AB02
ATC
metoprolol; systemic
1.9
10.6
193
1185
5314
FHL
Bypass surgery for four or more vessels
6.7
10.6
26
40
C10AB04
ATC
gemfibrozil; oral
10.3
10.6
20
20
SPAT1249
SPAT
Treatment-related counselling outside office
0.5
10.6
78
1480
Z96.4
ICD-10 Finland
Presence of endocrine implants
+∞
10.4
10
*
2500C
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,MODY]
+∞
10.4
10
*
A10BX02
ATC
repaglinide; oral
+∞
10.4
10
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
10.4
66
248
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
16.3
10.4
16
10
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
16.3
10.4
16
10
L15
ICPC
Knee symptom/complaint
0.3
10.3
18
633
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
23.8
10.3
14
6
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.2
10.3
9
467
M01AX05
ATC
glucosamine; oral
0.4
10.1
33
857
G04AB05
ATC
NA
4.1
10.1
38
96
G04AA01
ATC
NA
5.7
10.1
28
51
AA1AD
NOMESCO Finland
CT of head and brain
0.4
10.0
50
1091
B01AF02
ATC
apixaban; oral
0.1
10.0
6
398
L03
ICPC
Low back symptom/complaint
0.3
9.9
26
744
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
9.8
73
302
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
0.1
9.8
6
392
C02CA01
ATC
prazosin; oral
5.5
9.8
28
53
L28
ICPC
Limited function/disability (L)
0.3
9.7
25
723
C07AG02
ATC
carvedilol; oral
2.9
9.7
60
221
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.7
9.7
32
71
5253
FHL
Cardiac lung machine
7.0
9.7
23
34
N02AC04
ATC
dextropropoxyphene; oral
3.0
9.6
55
193
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
4.7
9.5
31
68
B03XA02
ATC
darbepoetin alfa; parenteral
5.5
9.4
27
51
V03AE02
ATC
sevelamer; oral
30.5
9.4
12
*
G63.2
ICD-10 Finland
Diabetic polyneuropathy
+∞
9.4
9
*
N0830, E112
ICD-10 Finland
NA
+∞
9.4
9
*
H3602, E113
ICD-10 Finland
NA
+∞
9.4
9
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
+∞
9.4
9
*
2508A
ICD-9 Finland
Diabetes mellitus, Diabetes with other specified manifestations[DIABETES MELLITUS CUM COMPLICAT NON DESCR,TYP II]
+∞
9.4
9
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
5.0
9.4
29
60
C07AB08
ATC
celiprolol; oral
3.8
9.4
39
108
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
4.9
9.3
29
61
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.5
9.3
90
1578
N17
ICPC
Vertigo/dizziness
0.2
9.2
7
398
J01XX05
ATC
methenamine; oral
5.3
9.2
27
53
R05
ICPC
Cough
0.3
9.2
25
702
K78
ICPC
Atrial fibrillation/flutter
0.2
9.1
6
374
B04AC04
ATC
NA
9.2
9.1
18
20
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
15.8
9.1
14
9
D03AX01
ATC
cadexomer iodine; topical
37.2
9.0
11
*
I20.00
ICD-10 Finland
Unstable angina
3.3
9.0
44
139
315
Kela drug reimbursment
Clopidogrel
6.2
9.0
23
38
B04AB02
ATC
NA
3.9
8.9
36
97
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.5
8.9
72
308
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.7
8.9
38
108
I20.09
ICD-10 Finland
Unstable angina
2.7
8.9
60
235
4111X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]
6.1
8.8
23
39
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
3.6
8.8
38
109
M01AB05
ATC
diclofenac; systemic, rectal
0.6
8.7
208
2881
D03BA02
ATC
collagenase; topical
9.1
8.6
17
19
Z94.0
ICD-10 Finland
Kidney transplant status
9.1
8.6
17
19
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.5
8.6
75
1359
L17
ICPC
Foot/toe symptom/complaint
0.4
8.5
33
801
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
27.9
8.5
11
*
D19
ICPC
Teeth/gum symptom/complaint
0.4
8.5
27
712
SPAT1100
SPAT
Long-term monitoring of blood pressure
0.1
8.5
*
313
9571
FHL
Amputation of toe or toes
91.1
8.4
9
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.2
8.4
10
432
A10AB06
ATC
insulin glulisine; parenteral
+∞
8.3
8
*
N0830, E102
ICD-10 Finland
NA
+∞
8.3
8
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
8.3
8
*
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
8.3
8
*
2508B
ICD-9 Finland
Diabetes mellitus, Diabetes with other specified manifestations[DIABETES MELLITUS CUM COMPLICAT NON DESCR,TYP I]
+∞
8.3
8
*
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
+∞
8.3
8
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.7
8.3
17
20
N03AF01
ATC
carbamazepine; oral, rectal
3.0
8.3
48
170
3661A
ICD-9 Finland
Cataract, Senile cataract
3.5
8.3
37
109
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.1
8.3
*
309
J01CF02
ATC
cloxacillin; systemic
4.3
8.3
29
69
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
8.3
346
4255
C02DE02
ATC
NA
4.2
8.3
30
74
N02AJ06
ATC
codeine and paracetamol; systemic
0.5
8.2
62
1178
A03FA02
ATC
cisapride; oral, rectal
2.4
8.2
70
310
D82
ICPC
Teeth/gum disease
0.5
8.2
51
1032
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
11.9
8.1
14
12
ZPB22
NOMESCO Finland
Autograft of vein
11.9
8.1
14
12
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
33.8
8.1
10
*
E87.5
ICD-10 Finland
Hyperkalaemia
5.1
8.1
24
48
J01XE01
ATC
nitrofurantoin; oral
4.1
8.0
30
76
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
22.3
8.0
11
5
EBA00
NOMESCO Finland
Extraction of tooth
0.5
8.0
55
1080
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.3
7.9
72
331
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
4.8
7.9
25
54
SPAT1260
SPAT
Consultation of another employee
0.3
7.9
21
596
S21
ICPC
Skin texture symptom/complaint
0.2
7.9
9
400
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
7.1
7.8
18
26
127
Kela drug reimbursment
Transplant complication
7.1
7.8
18
26
N06DX01
ATC
memantine; oral
0.3
7.8
13
468
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.4
7.8
34
785
L57.0
ICD-10 Finland
Actinic keratosis
0.3
7.8
14
485
C02AC05
ATC
moxonidine; oral
3.7
7.8
32
89
A01
ICPC
Pain general/multiple sites
0.1
7.7
*
248
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.5
7.7
35
105
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
2.9
7.7
46
168
J81
ICD-10 Finland
Pulmonary oedema
8.2
7.6
16
20
C03AA03
ATC
hydrochlorothiazide; oral
2.2
7.6
81
400
4110X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]
10.2
7.6
14
14
A02BC02
ATC
pantoprazole; systemic
0.6
7.5
224
2991
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.5
7.5
72
1273
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
4.7
7.4
24
53
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
80.9
7.4
8
*
CK2S4
SPAT
NA
80.9
7.4
8
*
M25.5
ICD-10 Finland
Pain in joint
0.4
7.4
40
853
SAA03
NOMESCO Finland
Extended examination of mouth
0.5
7.4
69
1230
Z71.8
ICD-10 Finland
Other specified counselling
0.4
7.3
36
798
SPAT1254
SPAT
Administration of medicine
0.4
7.3
29
701
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
11.0
7.3
13
12
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
+∞
7.3
7
*
A10BD07
ATC
metformin and sitagliptin; systemic
+∞
7.3
7
*
3620A
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA NON PROLIFERATIVA]
+∞
7.3
7
*
25007
ICD-8 Finland
Diabetes mellitus, Coma diabeticum
+∞
7.3
7
*
2510B
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemic coma[COMA HYPOGLYCAEMICUM]
+∞
7.3
7
*
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
7.3
7
*
R05FB02
ATC
cough suppressants and expectorants
1.6
7.3
240
1721
WX320
NOMESCO Finland
Spinalanesthesy
0.4
7.3
40
851
A29
ICPC
General symptom/complaint other
0.3
7.3
12
433
B01AF01
ATC
rivaroxaban; oral
0.2
7.2
9
381
N05CD07
ATC
temazepam; oral
1.8
7.2
125
745
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.4
7.2
23
604
S29
ICPC
Skin symptom/complaint other
0.3
7.2
20
559
3643
FHL
Vitrectomy through pars Plana
30.3
7.2
9
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.3
7.2
20
561
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.4
7.2
61
270
SPAT1304
SPAT
Counselling and guidance related to ageing
0.1
7.1
*
278
41300
ICD-8 Finland
Angina pectoris, Cum hypertonia
12.2
7.1
12
10
M01AC06
ATC
meloxicam; systemic, rectal
0.5
7.1
84
1402
R21
ICPC
Throat symptom/complaint
0.4
7.1
22
586
5313
FHL
Bypass surgery for three vessels
10.2
7.1
13
13
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
7.0
40
140
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
5.9
6.9
18
31
61
HP
Catheterization and pressure measurement of the left side of the heart
4.0
6.9
26
67
L04AA01
ATC
[U] ciclosporin; systemic
7.6
6.9
15
20
L13
ICPC
Hip symptom/complaint
0.3
6.9
16
488
I20.01
ICD-10 Finland
Unstable angina
3.4
6.8
31
94
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
9.4
6.8
13
14
4140X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]
6.2
6.8
17
28
G04BX05
ATC
NA
6.2
6.8
17
28
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
0.3
6.8
13
435
4120C
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,TROMBI]
40.4
6.8
8
*
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
40.4
6.8
8
*
I21.3
ICD-10 Finland
Acute transmural myocardial infarction of unspecified site
16.9
6.8
10
6
PFH59
NOMESCO Finland
Bypass from femoral or popliteal artery to distal anterior tibial artery
16.9
6.8
10
6
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
6.7
82
1360
104
Kela drug reimbursment
Thyroid insufficiency
2.4
6.7
56
247
C08CA05
ATC
nifedipine; systemic
2.3
6.7
61
281
G04BD12
ATC
mirabegron; oral
0.2
6.6
7
326
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.3
6.6
17
491
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.6
6.6
44
173
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
8.8
6.6
13
15
CKD40
NOMESCO Finland
Endophotocoagulation of retina
8.8
6.6
13
15
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
0.4
6.5
31
694
SPAT1149
SPAT
Suture or treatment of traumatic wound
0.3
6.5
15
456
EBA05
NOMESCO Finland
Complicated extraction of tooth
0.3
6.5
18
504
R01AD12
ATC
fluticasone furoate; nasal
0.5
6.5
41
831
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
70.4
6.4
7
*
R74
ICPC
Upper respiratory infection acute
0.4
6.4
36
759
WX290
NOMESCO Finland
Other blockade of nerve
0.5
6.3
74
1240
N06DA02
ATC
donepezil; oral
0.3
6.3
10
366
V03AE03
ATC
lanthanum carbonate; oral
18.2
6.3
9
5
E11.09
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - With coma
+∞
6.3
6
*
Z45.1
ICD-10 Finland
Adjustment and management of infusion pump
+∞
6.3
6
*
A10AE06
ATC
insulin degludec; parenteral
+∞
6.3
6
*
N0832, E102
ICD-10 Finland
NA
+∞
6.3
6
*
NHQ48
NOMESCO Finland
Revision of amputation of toe
+∞
6.3
6
*
A10BJ06
ATC
semaglutide; parenteral
+∞
6.3
6
*
2506X
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,NUD]
+∞
6.3
6
*
N08.30
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
+∞
6.3
6
*
A10BH05
ATC
linagliptin; oral
+∞
6.3
6
*
H360, E103
ICD-10 Finland
NA
+∞
6.3
6
*
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
+∞
6.3
6
*
R02
ICPC
Shortness of breath/dyspnoea
0.3
6.2
12
398
B01AC04
ATC
clopidogrel; oral
1.8
6.2
113
682
4140B
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]
4.7
6.1
19
41
SPAT1097
SPAT
Recording of ECG
0.4
6.1
21
537
I22.99
ICD-10 Finland
Recurrent infarction with unspecified location unspecified coronary artery status
12.7
6.1
10
8
C10AA02
ATC
lovastatin; oral
2.4
6.1
49
212
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.4
6.1
29
649
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
6.1
19
503
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.4
6.1
35
733
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.6
6.1
43
174
R06AX27
ATC
desloratadine; oral
0.5
6.1
40
800
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.5
6.1
67
1145
H02
ICPC
Hearing complaint
0.3
6.1
16
456
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
5.3
6.0
17
33

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010813) Leukocytes [#/volume] in Blood
214
5014
0.19
100.91
32.2
21.9
e9/l
7.2
6.8
1.36
204
4831
(3026361) Erythrocytes [#/volume] in Blood
214
5012
0.19
100.74
32.1
21.8
e12/l
4.4
4.4
0.03
204
4830
(3007461) Platelets [#/volume] in Blood
214
5010
0.19
100.56
32.3
21.8
e9/l
260.0
239.7
3.65
206
4842
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
184
4605
0.19
88.01
24.9
15.3
mg/l
24.3
27.1
0.68
145
3683
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
195
4686
0.20
87.08
13.6
9.3
u/l
24.4
24.7
0.12
186
4465
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
133
4110
0.17
85.71
4.9
3.8
mmol/l
8.3
5.6
14.58
114
3633
(40761511) CBC panel - Blood by Automated count
202
4677
0.21
82.16
21.7
14.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
209
4651
0.23
76.23
28.3
17.8
mmol/l
138.4
139.6
7.76
204
4487
(3023103) Potassium [Moles/volume] in Serum or Plasma
211
4660
0.23
75.68
28.6
17.9
mmol/l
4.1
4.0
3.10
205
4494
(3009542) Hematocrit [Volume Fraction] of Blood
167
4054
0.24
63.25
24.3
16.8
%
36.7
39.0
1.76
118
2795
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
172
3935
0.26
54.59
20.9
14.1
ml/min/173m2
76.1
75.2
0.14
153
3256
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
202
4117
0.29
49.33
6.3
4.2
mmol/l
2.3
2.7
12.93
191
3667
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
144
3498
0.27
47.55
9.9
6.5
u/l
98.3
83.8
1.35
135
3219
(3013707) Erythrocyte sedimentation rate by Westergren method
130
3326
0.26
46.58
5.8
3.8
mm/h
15.8
12.9
1.10
124
3006
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
197
3998
0.30
46.00
5.8
3.8
mmol/l
4.2
4.6
8.28
187
3588
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
193
3918
0.31
44.16
6.0
4.1
mu/l
2.1
2.0
0.23
179
3482
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
198
3958
0.31
43.76
5.8
3.7
mmol/l
1.5
1.5
0.66
187
3531
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
32
16
20.88
41.79
2.8
2.9
ug/min
44.1
57.3
—
15
7
(3037467) Urinalysis macro (dipstick) panel - Urine
132
3209
0.28
40.95
5.8
4.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
190
3813
0.32
40.92
5.0
3.4
mmol/l
1.1
1.2
1.07
178
3378
(3012516) Albumin [Mass/volume] in Urine
174
657
3.17
35.07
5.0
1.9
mg/l
356.0
373.1
0.02
131
374
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
25
11
23.50
34.23
1.2
1.0
iu/ml
36.0
—
—
7
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
101
2668
0.28
34.02
4.1
2.9
u/l
59.4
47.1
0.39
94
2438
(3044889) 12 lead EKG panel
134
3015
0.32
32.97
4.7
3.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
205
3760
0.37
32.87
12.7
3.8
mmol/mol
55.9
37.0
49.09
192
3367
(3020682) Albumin/Creatinine [Ratio] in Urine
174
699
2.96
31.13
6.0
2.3
mg/mmol
19.2
39.5
0.32
128
394
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
163
3186
0.37
28.05
4.7
3.4
pmol/l
15.0
14.9
0.30
153
2819
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
46
1742
0.21
26.66
2.7
5.3
ug/l
3.2
3.9
0.26
38
1528
(3013650) Neutrophils [#/volume] in Blood by Automated count
117
2610
0.34
26.05
11.4
8.5
e9/l
4.4
4.2
0.46
100
2255
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
98
2343
0.33
24.76
6.9
5.7
umol/l
11.7
13.6
0.78
89
2192
(3009508) Creatinine [Moles/volume] in Urine
172
766
2.63
24.73
4.9
2.4
mmol/l
7.2
7.5
0.43
158
645
(40768804) Tissue Pathology biopsy report
50
1690
0.24
23.51
2.5
2.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
71
1966
0.29
23.51
5.5
3.8
ng/l
85.6
48.0
0.45
58
1404
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
1406
0.19
22.61
2.8
4.5
%
28.3
21.8
0.97
15
713
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
1893
0.30
22.15
2.2
2.0
pmol/l
96.9
93.3
0.17
36
983
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
129
2566
0.39
20.74
3.4
3.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
93
2065
0.37
18.67
4.9
4.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
89
2015
0.36
18.64
15.5
10.2
inr
1.3
1.3
0.31
30
533
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
119
2369
0.40
18.54
15.7
6.5
mmol/l
1.2
1.2
0.54
103
1975
(3013115) Eosinophils [#/volume] in Blood
115
2291
0.41
17.72
9.2
6.1
e9/l
0.2
0.2
0.24
97
1988
(3009261) Glucose [Presence] in Urine by Test strip
109
2219
0.40
17.68
4.7
4.0
estimate
0.0
0.0
0.00
22
437
(3019198) Lymphocytes [#/volume] in Blood
113
2251
0.41
17.30
8.9
5.8
e9/l
1.8
1.8
0.19
95
1966
(3021601) Nitrite [Presence] in Urine by Test strip
108
2191
0.40
17.27
6.0
5.2
estimate
0.0
0.0
0.00
28
421
(3018010) Neutrophils/100 leukocytes in Blood
101
2107
0.39
17.25
9.6
5.9
%
55.6
57.7
0.78
95
1970
(3002030) Lymphocytes/100 leukocytes in Blood
105
2152
0.40
17.18
9.7
6.1
%
26.6
26.9
0.09
99
1994
(3013826) Glucose [Moles/volume] in Serum or Plasma
154
2713
0.45
17.17
9.8
4.6
mmol/l
9.5
6.2
21.08
144
2539
(3024561) Albumin [Mass/volume] in Serum or Plasma
101
2098
0.40
17.02
8.7
4.3
g/l
33.1
34.7
1.90
96
1906
(3001122) Ferritin [Mass/volume] in Serum or Plasma
84
1891
0.37
17.02
5.3
2.7
ug/l
171.7
142.6
0.53
79
1712
(3035350) Ketones [Presence] in Urine by Test strip
110
2201
0.41
16.92
4.7
3.9
estimate
0.0
0.0
0.00
25
429
(3001604) Monocytes [#/volume] in Blood
110
2198
0.41
16.85
8.9
5.8
e9/l
0.6
0.6
0.39
95
1884
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
111
2197
0.42
16.53
13.3
6.0
mmol/l
1.2
1.2
0.07
103
1947
(3018095) Leukocytes [#/volume] in Urine
78
1796
0.37
16.50
5.4
3.8
e6/l
62.8
156.1
1.29
56
1329
(3006315) Basophils [#/volume] in Blood
114
2213
0.42
16.05
8.7
5.8
e9/l
0.0
0.0
0.87
96
1905
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
21
999
0.19
16.01
2.0
3.2
ug/l
0.7
0.9
0.52
15
679
(3026008) Bacteria identified in Urine by Culture
63
1573
0.34
15.70
4.3
3.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
107
2109
0.42
15.52
9.3
6.2
%
8.4
8.9
1.01
101
1970
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
1852
0.39
15.43
5.0
3.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
107
2100
0.42
15.30
9.1
5.9
%
3.3
2.9
0.76
101
1949
(3022096) Basophils/100 leukocytes in Blood
103
2041
0.42
15.02
9.5
6.0
%
0.7
0.6
1.09
97
1904
(3021960) Folate [Moles/volume] in Serum or Plasma
35
1157
0.27
14.77
1.6
1.6
nmol/l
22.8
19.6
0.54
28
971
(3019309) Folate [Moles/volume] in Red Blood Cells
35
1121
0.28
13.87
2.3
1.8
nmol/l
1467.7
1154.5
0.75
30
823
(3021589) Normoblasts [#/volume] in Blood
100
1947
0.44
13.64
15.4
9.9
e9/l
0.0
0.0
0.93
78
1563
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
1725
0.41
13.56
5.3
4.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
37
1117
0.30
13.08
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
74
1600
0.40
12.97
4.9
3.4
e6/l
32.6
117.5
1.30
56
1249
(3044640) Blood type and Crossmatch panel - Blood
67
1493
0.39
12.54
2.9
2.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
66
1448
0.40
11.80
5.1
3.3
e6/l
0.5
0.5
0.04
47
1113
(36304419) Bacteria [Presence] in Urine
64
1407
0.40
11.45
4.8
3.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
59
1326
0.40
11.07
2.2
2.1
mg/l
3.1
3.0
0.17
52
1088
(42870588) Differential panel, method unspecified - Blood
74
1515
0.43
11.05
8.4
6.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
35
994
0.32
10.82
5.9
4.0
ng/l
141.3
319.1
1.18
30
835
(3013512) EKG study
60
1322
0.40
10.69
4.0
3.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
99
1787
0.48
10.38
2.8
2.2
nmol/l
75.7
77.5
0.32
90
1564
(3023368) Bacteria identified in Blood by Culture
74
1471
0.45
10.10
6.7
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
51
1164
0.40
9.78
8.1
6.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
37
974
0.35
9.72
1.7
1.6
pmol/l
386.3
14810571.4
0.80
29
790
(3018418) pH of Serum or Plasma
72
1409
0.46
9.32
11.9
3.5
ph
7.4
7.4
0.75
17
255
(3022217) INR in Platelet poor plasma by Coagulation assay
26
793
0.30
9.12
22.5
28.1
inr
1.9
1.5
—
5
97
(3041096) Erythrocytes [Presence] in Urine by Automated
55
1177
0.42
8.95
5.2
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
52
1132
0.42
8.81
2.7
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
61
1226
0.45
8.38
4.4
2.4
—
—
—
0
0
(3026782) Osmolality of Urine
48
1049
0.42
8.16
4.8
2.8
mosm/kgh2o
441.0
564.7
5.34
43
883
(3029937) Albumin [Presence] in Urine by Test strip
65
1253
0.47
7.91
5.3
4.3
estimate
0.0
0.0
0.69
26
412
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
42
942
0.41
7.57
1.5
2.1
mg/l
1.7
1.3
0.26
35
721
(3026493) Urate [Moles/volume] in Serum or Plasma
53
1078
0.45
7.44
3.5
2.8
umol/l
6316.4
7211.7
0.05
48
920
(3011397) Hemoglobin [Presence] in Urine by Test strip
52
1052
0.46
7.17
3.9
4.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
864
0.41
7.06
3.3
2.9
e6/l
0.7
1.1
0.59
16
506
(3019150) Specific gravity of Urine by Refractometry
51
1031
0.46
7.01
4.3
4.3
kg/l
1.0
1.0
0.33
12
149
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
37
841
0.41
6.86
3.3
3.1
e6/l
2.7
2.1
0.25
15
491
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
611
0.34
6.36
14.3
7.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
16
490
0.31
5.61
3.8
3.1
ng/l
832.3
308.9
1.35
16
450
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
911
0.49
5.44
1.6
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
23
560
0.39
4.99
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
414
0.30
4.93
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
17
455
0.36
4.56
6.4
4.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
28
604
0.44
4.53
1.6
1.3
iu/ml
17.5
26.7
1.30
12
184
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
655
0.46
4.49
1.7
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
111
0.00
4.41
0.0
1.2
—
—
—
0
0
(4146454)
8
9
8.97
4.29
3.7
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
50
868
0.54
4.24
8.8
4.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
33
654
0.48
4.23
1.7
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
354
0.33
3.96
1.8
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
29
587
0.47
3.96
1.7
1.3
u/ml
26.8
10.6
0.48
12
221
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
360
0.35
3.78
1.8
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
648
0.52
3.67
1.7
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
310
0.31
3.65
1.3
1.5
—
—
—
0
0
(3000492) Spirometry study
15
378
0.38
3.56
1.5
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
319
0.33
3.53
1.4
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
358
0.38
3.44
1.4
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
305
0.35
3.24
1.2
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
318
0.37
3.21
1.2
2.1
nmol/l
17.1
12.9
—
7
275
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
19
412
0.45
3.16
6.4
2.2
u/l
24.3
31.4
—
10
351
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
244
0.36
3.10
2.1
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
208
0.33
2.97
1.9
2.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
47
750
0.60
2.92
2.6
2.5
s
29.8
30.0
0.11
47
726
(3003396) Base excess in Arterial blood by calculation
31
553
0.54
2.90
11.2
6.2
mmol/l
0.5
1.4
0.37
21
424
(40768797) Stomach Pathology biopsy report
29
522
0.54
2.81
1.3
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
6
8.38
2.75
4.0
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
214
0.37
2.71
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
163
0.30
2.58
1.0
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
7
7.18
2.55
5.6
2.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
7
7.18
2.55
8.4
5.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
20
387
0.50
2.46
1.6
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
29
500
0.56
2.44
1.8
1.3
titre
813.3
475.5
—
9
107
(3028707) Methadone [Presence] in Urine by Screen method
0
63
0.00
2.43
0.0
2.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
6
177
0.33
2.42
2.3
2.8
u/ml
25.0
59.5
—
6
171
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
67
0.00
2.39
0.0
1.5
—
—
—
0
0
(4035726)
17
342
0.48
2.35
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
204
0.39
2.31
1.3
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
184
0.37
2.31
1.3
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
428
0.55
2.28
3.9
3.8
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
62
0.00
2.23
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
62
0.00
2.23
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
62
0.00
2.23
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
62
0.00
2.23
0.0
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
24
423
0.55
2.20
7.1
2.9
e9/l
67.8
63.8
0.28
19
327
(3000494) Fungus identified in Specimen by Culture
28
472
0.58
2.19
1.6
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
150
0.33
2.17
1.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
56
0.00
2.07
0.0
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
146
0.34
2.03
1.0
1.2
—
—
—
0
0
(4010399)
13
270
0.47
2.00
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
187
0.42
1.95
1.4
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
54
0.00
1.86
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
54
0.00
1.86
0.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
613
0.67
1.81
2.3
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
166
0.42
1.81
5.4
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
233
0.46
1.80
1.3
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
138
0.36
1.76
1.2
1.2
—
2.0
—
0
14
(40761536) Microorganisms panel - Urine sediment
24
391
0.60
1.69
7.0
4.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
15
278
0.53
1.68
14.9
9.0
%
93.6
93.7
0.03
15
278
(3030981) Hyaline casts [#/volume] in Urine by Automated count
14
265
0.52
1.67
3.2
2.6
e6/l
0.2
0.3
0.16
14
256
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
351
0.59
1.64
1.9
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
301
0.55
1.64
3.3
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
237
0.50
1.63
4.4
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
275
0.54
1.62
1.5
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
14
3.59
1.62
1.6
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
335
0.59
1.58
5.5
3.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
26
2.71
1.58
1.1
1.3
—
—
—
0
0
(4306422)
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
125
0.40
1.51
1.0
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
128
0.39
1.50
5.4
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
153
0.45
1.44
1.0
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
138
0.43
1.41
2.7
1.7
mg/l
1.4
3.0
—
6
95
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
223
0.53
1.39
1.3
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
37
0.00
1.34
0.0
1.4
—
6.8
—
0
25
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(4268621)
0
39
0.00
1.34
0.0
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
147
0.47
1.33
1.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
148
0.47
1.33
1.1
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
148
0.47
1.33
1.1
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
41
0.00
1.31
0.0
2.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
135
0.44
1.28
2.0
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
20
315
0.62
1.27
3.7
3.1
ml/min/173m2
43.6
63.3
1.79
15
132
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
37
512
0.71
1.25
4.7
3.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
9
171
0.52
1.19
2.4
2.1
ug/l
164.6
689.1
—
9
157
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
128
0.46
1.17
2.0
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
198
0.55
1.17
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
33
0.00
1.16
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
33
0.00
1.16
0.0
3.5
—
54.2
—
0
33
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
20
2.51
1.15
1.8
2.8
u/ml
1351.0
761.4
—
5
20
(3016018) Differential panel - Cerebral spinal fluid
0
36
0.00
1.14
0.0
3.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
221
0.58
1.14
1.3
1.3
—
49.6
—
0
14
(3004588) Protein electrophoresis panel - Serum or Plasma
22
329
0.66
1.13
1.5
2.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
20
304
0.65
1.11
10.2
4.3
%
0.0
0.0
—
6
87
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
12
207
0.57
1.11
1.7
1.9
ug/l
0.6
2.9
0.88
12
168
(3042936) Bacteria identified in Isolate by Culture
49
635
0.76
1.11
2.8
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
64
796
0.79
1.07
1.8
1.4
g/l
2.2
2.4
0.29
30
456
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
34
2.07
1.03
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
226
0.61
1.02
16.4
9.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
106
0.47
1.01
1.6
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
84
1.68
0.98
1.8
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
29
0.00
0.98
0.0
2.2
—
—
—
0
0
(4281824)
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
30
0.00
0.97
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
36
1.95
0.97
2.6
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
101
1.60
0.94
6.5
4.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
127
0.55
0.89
4.1
4.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
180
0.61
0.87
2.1
2.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
128
1.50
0.86
2.6
1.5
—
—
—
0
0
(4034850)
9
150
0.59
0.79
4.6
11.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
9
150
0.59
0.79
1.4
1.5
—
234.3
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.6
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
34.6
—
0
11
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
237.9
—
0
12
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
25
0.00
0.79
0.0
1.0
—
475.7
—
0
13
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
1.4
—
0
21
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
74
1.63
0.78
7.1
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
172
0.63
0.74
2.9
2.9
—
—
—
0
0
(3036489) Thrombin time
10
160
0.62
0.74
2.7
4.3
s
22.1
21.3
—
10
154
(3002179) Metamyelocytes/100 leukocytes in Blood
23
311
0.73
0.74
9.0
4.1
%
0.5
0.6
—
6
82
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
8
135
0.59
0.73
4.1
5.0
g/l
3.3
3.5
—
8
129
(4024509)
7
39
1.80
0.72
1.9
1.6
—
—
—
0
0
(3020891) Body temperature
13
193
0.67
0.70
3.8
4.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
24
319
0.74
0.70
8.8
4.2
%
0.1
0.1
—
8
97
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
118
0.59
0.68
2.1
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
18
248
0.72
0.66
1.9
1.8
g/l
1.2
1.6
0.72
18
223
(3021387) Prolactin [Units/volume] in Serum or Plasma
6
102
0.58
0.62
1.5
1.5
mu/l
295.2
317.9
—
6
93
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
40
487
0.81
0.61
2.5
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
20
266
0.74
0.60
8.8
5.4
g/l
121.7
124.6
0.17
20
261
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(4198724)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
27
343
0.78
0.59
7.9
4.1
%
1.2
0.9
0.32
11
110
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.0
—
165.4
—
0
22
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
22
0.00
0.59
0.0
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
115
0.60
0.58
1.0
1.1
—
9.2
—
0
14
(3043409) Potassium [Moles/volume] in Arterial blood
10
149
0.67
0.57
5.2
3.5
mmol/l
4.1
3.9
—
10
141
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
88
0.57
0.56
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
160
0.68
0.56
1.5
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
16
216
0.73
0.54
8.1
5.1
%
0.6
0.7
0.66
16
210
(3012441) Differential panel - Pleural fluid
9
61
1.48
0.54
1.7
1.3
—
—
—
0
0
(4062490)
6
39
1.54
0.53
1.5
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
6
98
0.61
0.52
8.7
5.0
mmol/l
14.2
11.3
—
6
87
(3018572) Chloride [Moles/volume] in Blood
6
98
0.61
0.52
8.7
5.0
mmol/l
102.7
104.9
—
6
87
(3047181) Lactate [Moles/volume] in Blood
9
134
0.67
0.52
7.8
4.8
mmol/l
2.0
1.4
—
9
118
(3007853) Bacteria identified in Skin by Aerobe culture
46
539
0.84
0.50
2.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
176
0.73
0.46
2.5
3.2
u/ml
0.4
0.4
—
6
100
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
77
1.44
0.45
4.5
3.8
%
65.9
60.9
0.52
11
77
(3022313) Gas panel - Capillary blood
22
275
0.79
0.45
4.6
5.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
404
0.83
0.44
2.6
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
104
1.35
0.43
7.1
7.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
56
1.43
0.42
2.0
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
94
0.64
0.42
3.5
1.6
mg/l
11.3
11.3
—
6
87
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.2
—
5.7
—
0
16
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
138
0.72
0.40
1.8
2.9
—
1.4
—
0
11
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.7
—
35.5
—
0
12
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
17
0.00
0.40
0.0
1.7
—
6.8
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
17
0.00
0.40
0.0
2.7
—
118.9
—
0
17
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.3
—
10.3
—
0
8
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
0.9
—
0
19
(1617658) Protocol used for examination of sentinel lymph nodes
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
13
170
0.76
0.38
6.9
4.1
%
1.5
1.6
0.12
13
157
(3011648) Oxygen content in Venous blood
5
36
1.39
0.38
10.4
18.6
%
10.6
10.8
—
5
36
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
246
0.81
0.37
1.7
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
8
115
0.69
0.37
5.1
3.8
mg/l
28.1
31.8
—
8
80
(21494890) Protein electrophoresis panel - 24 hour Urine
5
37
1.35
0.37
1.0
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
77
0.65
0.36
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
31
360
0.85
0.33
5.9
5.7
ph
7.4
7.4
—
5
34
(3007930) Methemoglobin/Hemoglobin.total in Blood
13
166
0.78
0.33
6.9
4.2
%
0.9
1.0
0.35
13
153
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.5
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
93
863
1.09
0.30
2.3
1.2
u/ml
5.7
1.4
0.80
26
211
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
93
1.30
0.30
1.3
1.4
miu/ml
233.9
273.4
—
5
43
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
110
0.72
0.29
6.6
2.3
g/l
130.1
128.6
—
8
84
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
30
344
0.87
0.28
5.9
5.8
mmol/l
0.9
2.0
0.79
22
259
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
76
1.32
0.28
4.7
3.3
e9/l
4.3
4.5
—
10
76
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
85
1.30
0.28
1.5
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
172
0.81
0.27
1.5
2.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
20
235
0.85
0.26
5.4
6.4
mmol/l
24.4
24.9
0.37
20
220
(3003434) Protein [Mass/volume] in Pleural fluid
9
72
1.25
0.25
1.6
1.4
g/l
29.5
28.9
—
9
64
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.8
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
7.7
—
0
11
(3016228) CD19 cells/100 cells in Blood
0
11
0.00
0.21
0.0
2.5
—
3.0
—
0
11
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
1.6
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
7.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
16.2
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
160.3
—
0
10
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.0
—
61.5
—
0
13
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
13
0.00
0.21
0.0
1.0
—
87.4
—
0
8
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
48
1.25
0.20
2.8
3.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.2
—
97.3
—
0
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
14
0.00
0.20
0.0
1.2
—
107.5
—
0
14
(3006653) Thiamine [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
129.0
—
0
14
(3036670) Protein [Mass/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.1
—
37.1
—
0
9
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
70
0.71
0.16
1.4
1.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
6
78
0.77
0.15
4.7
2.3
mmol/l
1.6
1.6
—
6
78
(3007566) Smooth muscle Ab [Titer] in Serum
7
90
0.78
0.14
2.1
1.2
—
91.3
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
97
0.82
0.13
1.8
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
100
0.80
0.13
8.3
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
87
906
0.95
0.13
2.2
1.6
mmol/l
1.0
1.2
3.95
80
767
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
117
0.85
0.13
2.7
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
126
0.87
0.11
1.3
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
126
0.87
0.11
1.3
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
55
1.09
0.09
1.3
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
61
0.82
0.08
1.4
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
60
0.83
0.08
7.8
2.1
pg
35.0
32.4
—
5
60
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
64
1.09
0.08
1.4
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
65
1.08
0.08
1.9
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
8
76
1.05
0.07
4.1
3.5
u/ml
38970.5
482.7
—
8
71
(3019230) Fractional oxyhemoglobin in Venous blood
9
86
1.05
0.07
9.0
8.7
%
73.7
62.0
—
9
86
(40760888) Immunoglobulin light chains.free panel - Serum
8
94
0.85
0.06
1.5
3.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
325
1.05
0.06
1.3
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
106
0.94
0.01
1.3
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
105
1.05
0.00
1.6
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
41
414
0.99
0.00
12.0
8.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
129
1.01
0.00
1.5
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
47
471
1.00
0.00
8.8
5.6
mmol/l
0.8
1.8
0.90
39
372
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.3
—
0.7
—
0
8
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
80
1.00
0.00
1.4
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
21.2
—
0
9
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
2.5
—
0
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
54
0.93
0.00
1.4
1.7
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
71
0.99
0.00
1.4
1.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
5.0
—
0
5
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
74.0
—
0
5
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
6
0.00
0.00
0.0
2.7
—
85.5
—
0
6
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
60.4
—
0
5
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
2.7
—
1208.2
—
0
6
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
162.5
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
56
0.89
0.00
1.6
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint T1D_WIDE2 and mortality.

Females

Parameter HR [95% CI] p-value
T1D_WIDE2 6.681 [5.35, 8.35] < 0.001
Birth year 0.996 [0.99, 1.0] 0.368

During the follow-up period (1.1.1998 — 31.12.2019), 331 out of 651 females with T1D_WIDE2 died.

Males

Parameter HR [95% CI] p-value
T1D_WIDE2 7.376 [6.0, 9.07] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 592 out of 1001 males with T1D_WIDE2 died.

Mortality risk

Mortality risk for people of age

years, who have T1D_WIDE2.

N-year risk Females Males
1 0.619% 1.217%
5 4.152% 8.264%
10 9.596% 19.66%
15 17.983% 34.211%
20 28.735% 51.143%

Relationships between endpoints

↥

Index endpoint: T1D_WIDE2 – Type 1 diabetes, wide definition, subgroup 2

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data